2,857
+2.00%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Suzuken Co
Its shares trade on Tokyo Stock Exchange under the ticker 9987.T. It has been listed since 1 August 1994. In the fiscal year to 31 March 2026, it reported revenue of ¥2.49trn and net income of ¥38.14bn. At that date it held total assets of ¥1.16trn and shareholders' equity of ¥415.88bn.
Suzuken Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Nagoya, Aichi-Ken. The firm operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 1 Aug 1994
- Employees
- 15,477
- Website
- suzuken.co.jp ↗
Leadership
Pay as last reported
- Mr. Hiromi MiyataChairman of the Executive Board, Director, since 2011
- Mr. Shigeru AsanoExecutive President, Chief Executive Officer, Representative Director, since 2009
- Mr. Hirofumi TanakaSenior Managing Executive Officer, Chief Director of Healthcare Distribution Business, Director, since 2015
- Mr. Akihiko SomeyaManaging Executive Officer, Director of Nagoya Sales, since 2015
- Mr. Osamu AbeSenior Executive Officer, Director of Osaka Sales
- Mr. Naoaki KatoSenior Executive Officer, Director of Tokyo Central Sales
- Mr. Toyoaki OhtaSenior Executive Officer, Deputy Chief Director of Main Group Administration Unit, Director of Human Resources and General Affairs
- Ms. Chie TakahashiSenior Executive Officer, Chief Director of Medical and Nursing Support Business, Director of Business Planning, Director, since 2020
- Mr. Takahiro KuroyanagiSenior Executive Officer, Director of Sales Promotion
- Mr. Yoshihiro OhtsukaSenior Executive Officer, Senior Director of Insurance Pharmacy
- Mr. Masayuki TanakaSenior Executive Officer, Chief Director of Group Administration
- Mr. Yasuyoshi FujiiExecutive Officer, Director of Aiseikan Sales
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 41
- Environment
- 39
- Social
- 37
- Governance
- 47
- Direct emissions (scope 1)
- 26,491 t
- Energy emissions (scope 2)
- 46,095 t
- Women in the workforce
- 53.7%
- Carbon reduction policy
- Yes
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Suzuken Co Ltd possesses several strengths that contribute to its competitive advantage:
Weaknesses
- However, Suzuken Co Ltd also has certain weaknesses that pose challenges:
Opportunities
- Suzuken Co Ltd can leverage the following opportunities for growth:
Threats
- Suzuken Co Ltd faces several threats that could potentially impact its business:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.